Alert: Alzheimer’s Drug Fails in Clinical Trial-Stocks Sink: ACIU,BIIB,LLY…Update-1
Another clinical trial failure for an Alzheimer's Disease in a late stage trial triggered a pre-market sell-off. Both Biogen (BIIB) -aducanumab- and Lilly (LLY)- solanezumab -drugs in development are engineered antibodies that attack beta amyloid targets in the brain. At the close 11/23: ACIU...
Rayno Biobeat #4: Sector Shift Underway but what’s next for biotech?…Update-1
Update-1 November 28 Another nasty day for biotech A bit of a selloff in the market indices today with the NASDAQ down 0.58% and the S&P down 0.53%. The highly touted Russell 2000 (IWM) was down 1.3% after a 15 day rally. But the real wreck was in biotech with the XBI down 3.09% and the IBB...
Trump Biotech Rally: After Comey Sell-Off and Since Election
Trump Biotech Rally-Have a Balanced Portfolio Everybody who invests in biotech knows there has been a Trump biotech rally since his election as you can see from the chart and data below. Many opinions and analysis were given for the rally.Some pundits say it is because the end of the...
Rayno Biobeat #3…Trump Biotech Rally Leads Market Up
Trump Election Win Drives Huge Biotech Rally NASDAQ up over 1% to 5248 The Trump biotech rally began at today's opening up (IBB) 20 points to $280 then held to close up 8.9% to $285. The XBI soared 10.4% to close at $63.8 near highs of day. The cloud of drug pricing concerns vanished because...
Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals- Update-1
Which Large Cap Biopharma Stocks Have the Best Value? But revenue growth is slowing so M&A must pick up. Drug stocks have gone through a severe correction and healthcare is one of the worse sectors YTD. Although the key indicators are still sketchy, now is the time to look for value among...